Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Sep 12, 2025

Accession no.
0001628280-25-041989
Filed
Sep 12, 2025
Trade date
Aug 1-29, 2025
Filing delay
42 daysLate
Rule 10b5-1 plan
Checked

This filing lists 21 non-derivative transactions and 0 derivative transactions. Open-market purchases total $397.89. It was filed 42 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 1, 2025Common StockPPurchaseAcquired+6$3.44+$20.6432,827Direct
Aug 4, 2025Common StockPPurchaseAcquired+6$4.01+$24.0632,833Direct
Aug 5, 2025Common StockPPurchaseAcquired+6$3.92+$23.5232,839Direct
Aug 6, 2025Common StockPPurchaseAcquired+6$3.34+$20.0432,845Direct
Aug 7, 2025Common StockPPurchaseAcquired+6$3.14+$18.8432,851Direct
Aug 8, 2025Common StockPPurchaseAcquired+6$3.39+$20.3432,857Direct
Aug 11, 2025Common StockPPurchaseAcquired+6$2.87+$17.2232,863Direct
Aug 12, 2025Common StockPPurchaseAcquired+6$2.91+$17.4632,869Direct
Aug 13, 2025Common StockPPurchaseAcquired+6$2.94+$17.6432,875Direct
Aug 14, 2025Common StockPPurchaseAcquired+6$2.84+$17.0432,881Direct
Aug 15, 2025Common StockPPurchaseAcquired+6$3.02+$18.1232,887Direct
Aug 18, 2025Common StockPPurchaseAcquired+6$3.11+$18.6632,893Direct
Aug 19, 2025Common StockPPurchaseAcquired+6$3.23+$19.3832,899Direct
Aug 20, 2025Common StockPPurchaseAcquired+1$3.15+$3.1532,900Direct
Aug 21, 2025Common StockPPurchaseAcquired+6$3.25+$19.532,906Direct
Aug 22, 2025Common StockPPurchaseAcquired+6$3.31+$19.8632,912Direct
Aug 25, 2025Common StockPPurchaseAcquired+6$3.32+$19.9232,918Direct
Aug 26, 2025Common StockPPurchaseAcquired+6$3.39+$20.3432,924Direct
Aug 27, 2025Common StockPPurchaseAcquired+6$3.44+$20.6432,930Direct
Aug 28, 2025Common StockPPurchaseAcquired+6$3.47+$20.8232,936Direct
Aug 29, 2025Common StockPPurchaseAcquired+6$3.45+$20.732,942Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)